Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinya Sato

Showing results (341-350 of 514) with videos related to

Pageof 52
Sort By:
Archivos Espanoles De Urologia|December 6, 2023
Review of the Developing Landscape of Prostate Biopsy and Its Roles in Prostate Cancer Diagnosis and TreatmentYoichiro Okubo, Shinya Sato, Hideyuki Terao, et al.
International Journal of Molecular Sciences|June 6, 2019
Exogenous Administration of Low-Dose Lipopolysaccharide Potentiates Liver Fibrosis in a Choline-Deficient l-Amino-Acid-Defined Diet-Induced Murine Steatohepatitis ModelKeisuke Nakanishi, Kosuke Kaji, Mitsuteru Kitade, et al.
Human Cell|January 1, 2013
Establishment and characterization of a novel ovarian serous adenocarcinoma cell line, TU-OS-4, that overexpresses EGFR and HER2Hiroaki Itamochi, Misaki Kato, Mayumi Nishimura, et al.
Oncology Reports|June 14, 2014
The PI3K/mTOR dual inhibitor NVP-BEZ235 reduces the growth of ovarian clear cell carcinomaTetsuro Oishi, Hiroaki Itamochi, Akiko Kudoh, et al.
International Journal of Molecular Sciences|July 29, 2025
Rifaximin Attenuates Liver Fibrosis and Hepatocarcinogenesis in a Rat MASH Model by Suppressing the Gut-Liver Axis and Epiregulin-IL-8-Associated AngiogenesisNaoki Nishimura, Kosuke Kaji, Norihisa Nishimura, et al.
Heliyon|October 14, 2024
Cabozantinib prevents the progression of metabolic dysfunction-associated steatohepatitis by inhibiting the activation of hepatic stellate cell and macrophage and attenuating angiogenic activityTakuya Matsuda, Kosuke Kaji, Norihisa Nishimura, et al.
International Journal of Clinical Oncology|July 11, 2026
Clinical utility of diagnosing lynch syndrome in gynecologic oncology: a joint statement from four japanese academic societiesShinya Sato, Kenta Masuda, Katsutoshi Oda, et al.
ACS Chemical Biology|January 13, 2023
Discovery of 2,6-Dihalopurines as Stomata Opening Inhibitors: Implication of an LRX-Mediated H<sup>+</sup>-ATPase Phosphorylation PathwayAyaka Ueda, Yusuke Aihara, Shinya Sato, et al.
Human Cell|November 26, 2025
Establishment of immortalized ovarian stromal cell lines using Sendai virus vectors: a platform for studying tumor-stroma interactions and carcinogenesisMasayo Okawa, Hiroaki Komatsu, Yasuhiro Kazuki, et al.
Cancer Science|November 10, 2025
A Combinatorial Effect of Immune Checkpoint Inhibitors and CD40 Agonistic Antibody in Murine Pancreatic Cancer ModelJuri Ichikawa, Hiroshi Okuda, Kuniyuki Kawano, et al.
Pageof 52

Showing results (341-350 of 514) with videos related to

Sort By:
Pageof 52
Archivos Espanoles De Urologia|December 6, 2023
Review of the Developing Landscape of Prostate Biopsy and Its Roles in Prostate Cancer Diagnosis and TreatmentYoichiro Okubo, Shinya Sato, Hideyuki Terao, et al.
International Journal of Molecular Sciences|June 6, 2019
Exogenous Administration of Low-Dose Lipopolysaccharide Potentiates Liver Fibrosis in a Choline-Deficient l-Amino-Acid-Defined Diet-Induced Murine Steatohepatitis ModelKeisuke Nakanishi, Kosuke Kaji, Mitsuteru Kitade, et al.
Human Cell|January 1, 2013
Establishment and characterization of a novel ovarian serous adenocarcinoma cell line, TU-OS-4, that overexpresses EGFR and HER2Hiroaki Itamochi, Misaki Kato, Mayumi Nishimura, et al.
Oncology Reports|June 14, 2014
The PI3K/mTOR dual inhibitor NVP-BEZ235 reduces the growth of ovarian clear cell carcinomaTetsuro Oishi, Hiroaki Itamochi, Akiko Kudoh, et al.
International Journal of Molecular Sciences|July 29, 2025
Rifaximin Attenuates Liver Fibrosis and Hepatocarcinogenesis in a Rat MASH Model by Suppressing the Gut-Liver Axis and Epiregulin-IL-8-Associated AngiogenesisNaoki Nishimura, Kosuke Kaji, Norihisa Nishimura, et al.
Heliyon|October 14, 2024
Cabozantinib prevents the progression of metabolic dysfunction-associated steatohepatitis by inhibiting the activation of hepatic stellate cell and macrophage and attenuating angiogenic activityTakuya Matsuda, Kosuke Kaji, Norihisa Nishimura, et al.
International Journal of Clinical Oncology|July 11, 2026
Clinical utility of diagnosing lynch syndrome in gynecologic oncology: a joint statement from four japanese academic societiesShinya Sato, Kenta Masuda, Katsutoshi Oda, et al.
ACS Chemical Biology|January 13, 2023
Discovery of 2,6-Dihalopurines as Stomata Opening Inhibitors: Implication of an LRX-Mediated H<sup>+</sup>-ATPase Phosphorylation PathwayAyaka Ueda, Yusuke Aihara, Shinya Sato, et al.
Human Cell|November 26, 2025
Establishment of immortalized ovarian stromal cell lines using Sendai virus vectors: a platform for studying tumor-stroma interactions and carcinogenesisMasayo Okawa, Hiroaki Komatsu, Yasuhiro Kazuki, et al.
Cancer Science|November 10, 2025
A Combinatorial Effect of Immune Checkpoint Inhibitors and CD40 Agonistic Antibody in Murine Pancreatic Cancer ModelJuri Ichikawa, Hiroshi Okuda, Kuniyuki Kawano, et al.
Pageof 52